Q4 2016 Holdings
Filed 2017-02-13 | 22 holdings | $63.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $38.4M | 6,071,142 | 60.8% |
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $14.6M | 721,152 | 23.1% |
| CytomX Therapeutics Inc(CTMX) | COM | 23284F105 | $6.4M | 577,831 | 10.1% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $3.6M | 129,629 | 5.8% |
| AveXis Inc | COM | 05366U100 | $49.4K | 1,035,657 | 0.1% |
| Edge Therapeutics Inc | COM | 279870109 | $24.2K | 1,933,582 | 0.0% |
| DBV Technologies | COM | F2927N109 | $18.7K | 373,617 | 0.0% |
| Audentes Therapeutics(BOLDEUR) | COM | 05070R104 | $8.2K | 458,882 | 0.0% |
| Ra Pharmaceuticals | COM | 74933V108 | $8.2K | 542,500 | 0.0% |
| CoLucid Pharmaceuticals | COM | 19716T101 | $5.8K | 159,110 | 0.0% |
| Axovant Sciences Ltd | COM | G0750W104 | $5.3K | 429,590 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $5.3K | 405,901 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $3.4K | 315,980 | 0.0% |
| Alcobra Ltd | COM | M2239P109 | $3.2K | 1,537,463 | 0.0% |
| Arca biopharma Inc | COM | 00211Y100 | $3.1K | 1,078,932 | 0.0% |
| Akari Therapeutics Plc | COM | 00972G108 | $2.6K | 369,490 | 0.0% |
| Ocera Therapeutics | COM | 67552A108 | $2.6K | 1,217,872 | 0.0% |
| Lipocine Inc | COM | 53630X104 | $1.5K | 420,000 | 0.0% |
| Aeglea BioTherapeutics(AGLEUSD) | COM | 00773J103 | $1.5K | 350,133 | 0.0% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $1.3K | 221,651 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $812 | 280,000 | 0.0% |
| ProNAI Therapeutics Inc | COM | 74346L101 | $195 | 130,798 | 0.0% |